BioNTech SE 2025 SR
The report highlights BioNTech's progress in 2025 as it advances its transition toward becoming a diversified multi-product immunotherapy company by 2030. The company maintained its market leadership in the COVID-19 vaccine market with a 50% market share during the fall vaccination season and progressed its oncology pipeline with over 25 Phase 2 or 3 clinical trials. On the sustainability front, BioNTech strengthened its ESG data processes, appointed an additional Human Rights Officer, and achieved ISO 14001 and ISO 45001 certifications covering approximately 70% of its employees. Additionally, the company increased its renewable energy consumption to 75% and successfully validated its near-term emission reduction targets with the Science Based Targets initiative.
Company: BioNTech SE
Sector: Professional & technical services
Country: Germany
Year: 2025
Type: SR
Pages: 112
BioNTech SE
The report highlights BioNTech's progress in 2025 as it advances its transition toward becoming a diversified multi-product immunotherapy company by 2030. The company maintained its market leadership in the COVID-19 vaccine market with a 50% market share during the fall vaccination season and progressed its oncology pipeline with over 25 Phase 2 or 3 clinical trials. On the sustainability front, BioNTech strengthened its ESG data processes, appointed an additional Human Rights Officer, and achieved ISO 14001 and ISO 45001 certifications covering approximately 70% of its employees. Additionally, the company increased its renewable energy consumption to 75% and successfully validated its near-term emission reduction targets with the Science Based Targets initiative.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jan 1, 2025 - Dec 31, 2025
Fiscal Year
2025
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees